Journal of the Chinese Medical Association
Volume 70, Issue 6 , Pages 241-244, June 2007

Assessment of Left Ventricular Dysfunction in Children Undergoing Chemotherapy

Department of Pediatrics, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.

Received 23 October 2006; accepted 29 March 2007.

Article Outline

Background

In Taiwan, children with malignancies are treated under the protocols of the Taiwan Pediatric Oncology Group (TPOG). The purpose of this study was to determine the change in left ventricular (LV) function in pediatric patients undergoing chemotherapy.

Methods

A total of 19 pediatric patients (mean age, 12.5 ± 4.6 years; 11 males, 8 females) were enrolled. We divided the patients into 2 groups: (1) osteogenic sarcoma (OGS) group (n = 12; Group I); and (2) non-osteogenic sarcoma (non-OGS) group (n = 7; Group II). The accumulated dosages of anthracycline in Group I and II patients were 144.3 ± 56.4 mg/M2 and 131.7 ± 105.5 mg/M2 (p= 0.735), respectively. The children received echocardiography to investigate the parameters of LV systolic function, LV diastolic function, and myocardial performance index (MPI) after the entire chemotherapy course.

Results

Higher E/A ratio (1.71 ± 0.37), shorter isovolumic relaxation time (IRT, 42 ± 19.14 ms), and shorter deceleration time (DT, 140.3 ± 40.6 ms) were demonstrated in these patients. There was no statistically significant difference in the E/A ratio and DT between the 2 groups. Group I children were older (14.4 ± 3.7 vs. 9.3 ± 4.5 years; p = 0.015) and had lower MPI (0.20 ± 0.02 vs. 0.28 ± 0.07; p = 0.031) than Group II children.

Conclusion

The children treated with chemotherapy using the TPOG protocol had a shorter IRT, higher E/A ratio and shorter DT. No significant evidence of anthracycline-related cardiotoxicity was found in any of the children in this study undergoing chemotherapy with the TPOG protocol.

Key Words:  anthracycline , chemotherapy , children , left ventricular dysfunction

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lubomir E , Hana H , Vaclav C . The late consequences of anthra-cycline treatment of left ventricular function after treatment for childhood cancer . Eur J Pediatr . 2003;162:690–696
  2. Giantris A , Abdurrahman L , Hinkle A , Asselin B , Lipshultz SE . Anthracycline-induced cardiotoxicity in children and young adults . Critical Rev Oncol Hematol . 1998;4:53–68
  3. Wang JH , Chang TK , Hsieh YL , Hwang BT . Non-Hodgkin's lymphoma in childhood-five-year survey in VGH-Taipei . J Chin Med Assoc . 1989;44:249–255
  4. Sahn DJ , DeMaria A , Kisslo J , Weyman A . Recommendations regarding quantitation in M-mode echocardiography: result of survey of echocardiographic measurements . Circulation . 1978;58:1072–1083
  5. Harada K, Suzuki T, Tamura M, Harada K, Suzuki T, Tamura M, et al  Role of age on transmitral flow velocity patterns in assessing left ventricle diastolic function in normal infants and children . Am J Cardiol . 1995;76:530–532
  6. Hashimoto I, Ichida F, Miura M, Okabe T, Kanegane H, Uese K, et al  Automatic border detection identifies sub-clinical anthracycline cardiotoxicity in children with malignancy . Circulation . 1999;23:67–70
  7. Hesseling PB , Kalis NN , Wessels G , van der Merwe PL . The effect of anthracyclines on myocardial function in 50 long-term survivors of childhood cancer . S Afr Med J . 1999;89:25–28
  8. Billingham ME , Masek MA . The pathology of anthracycline cardiotoxicity in children, adolescents and adults . In:  Bricker JT ,  Green DM ,  D'Angio G editor. Cardiac Toxicity After Treatment for Childhood Cancer . New York: Wiley-Liss; 1993;p. 17–24
  9. Von Hoff DD , Rozencweig M , Layard M , Slavik M , Muggia FM . Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases . Am J Med . 1977;62:200–208
  10. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al  New index of combined systolic and diastolic myocardial performance-a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyo-pathy . J Cardiol . 1995;26:357–366
  11. Tei C . New noninvasive index for combined systolic and diastolic ventricular function . J Cardiol . 1995;26:135–136
  12. Tei C , Nishimura RA , Seward JB , Tajik AJ . Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements . J Am Soc Echocardiogr . 1997;10:169–178
  13. Williams RV , Saskia R , Tani LY , Pagotto LT , Minich LL . Quantitative assessment of ventricular function in children with single ventricles using the Doppler myocardial performance index . Am J Cardiol . 2000;86:1106–1110
  14. Eiden BW , Tei C , O'Leary PW , Cetta F , Seward JB . Non-geometric quantitative assessment of right and left ventricular function: myocardial performance index in normal children and patients with Ebstein anomaly . J Am Soc Echocardiogr . 1998;11:849–856
  15. Haque A, Otsuji Y, Yoshifuku S, Kumanhoso T, Zhang H, Kisanuki A, et al  Effects of valve dysfunction on Doppler Tei index . J Am Soc Echocardiogr . 2002;15:877–883
  16. Yeo T , Dujardin K , Tei C , Mahoney D , McGoon M , Seward J . Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension . Am J Cardiol . 1998;81:1157–1161
  17. Ishi M, Tsutsumi T, Himeno W, Eto G, Furui J, Hashino K, et al  Sequential evaluation of left ventricular myocardial performance in children after anthracycline . Am J Cardiol . 2000;86:1279–1281

PII: S1726-4901(09)70366-1

doi:10.1016/S1726-4901(09)70366-1

Journal of the Chinese Medical Association
Volume 70, Issue 6 , Pages 241-244, June 2007

Article Tools